Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Naltrexone hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely naltrexone hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naltrexone hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing morphine sulfate and naltrexone hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Morphine sulfate 20mg + naltrexone hydrochloride 800microgram m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Morphine sulfate 30mg + naltrexone hydrochloride 1.2mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Morphine sulfate 60mg + naltrexone hydrochloride 2.4mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Morphine sulfate 50mg + naltrexone hydrochloride 2mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Morphine sulfate 100mg + naltrexone hydrochloride 4mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Morphine sulfate 80mg + naltrexone hydrochloride 3.2mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naltrexone hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naltrexone hydrochloride 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely naltrexone hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely naltrexone hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naltrexone hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naltrexone hydrochloride 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Morphine sulfate 30mg + naltrexone hydrochloride 1.2mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Morphine sulfate 100mg + naltrexone hydrochloride 4mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Morphine sulfate 60mg + naltrexone hydrochloride 2.4mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Morphine sulfate 50mg + naltrexone hydrochloride 2mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Morphine sulfate 80mg + naltrexone hydrochloride 3.2mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Morphine sulfate 20mg + naltrexone hydrochloride 800microgram prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naltrexone hydrochloride 50 mg oral tablet |
Has precise active ingredient |
True |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely naltrexone hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naltrexone hydrochloride 100 mg oral tablet |
Has precise active ingredient |
True |
Naltrexone hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |